Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard K. Valicenti, MD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Oncology Services Foundation
Phoenix, Arizona, United States
- Auburn Radiation Oncology
Auburn, California, United States
- Radiation Oncology Centers - Cameron Park
Cameron Park, California, United States
- Mercy Cancer Center at Mercy San Juan Medical Center
Carmichael, California, United States
- Kaiser Permanente Medical Center - Los Angeles
Los Angeles, California, United States
- Radiation Oncology Center - Roseville
Roseville, California, United States
- Mercy General Hospital
Sacramento, California, United States
- Radiological Associates of Sacramento Medical Group, Incorporated
Sacramento, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Solano Radiation Oncology Center
Vacaville, California, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- University of Florida Shands Cancer Center
Gainesville, Florida, United States
- John B. Amos Cancer Center
Columbus, Georgia, United States
- Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, United States
- Hudner Oncology Center at Saint Anne'S Hospital - Fall River
Fall River, Massachusetts, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Regional Cancer Center at Singing River Hospital
Pascagoula, Mississippi, United States
- David C. Pratt Cancer Center at St. John'S Mercy
St Louis, Missouri, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Billings Clinic - Downtown
Billings, Montana, United States
- Stony Brook University Cancer Center
Stony Brook, New York, United States
- Mcdowell Cancer Center at Akron General Medical Center
Akron, Ohio, United States
- Summa Center for Cancer Care at Akron City Hospital
Akron, Ohio, United States
- Barberton Citizens Hospital
Barberton, Ohio, United States
- Robinson Radiation Oncology
Ravenna, Ohio, United States
- Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States
- Sentara Cancer Institute at Sentara Norfolk General Hospital
Norfolk, Virginia, United States
- Coastal Cancer Center at Sentara Virginia Beach General Hospital
Virginia Beach, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2008
- Primary completion
- 31 Jul 2014
- Completion
- 31 Dec 2016
- Last update posted
- 25 Jul 2017
- Registered enrollment
- 67
- Registry id
- NCT00551525
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.